Letters to the Editor Editor:
I have read with great interest the article on ''follicular stem cell carcinomas'' by Drs. Mikaelian and Wong 8 in your July 2003 issue as well as the subsequent letter to the editor by the same authors in the May 2004 issue. I applaud the authors for collecting such large numbers of these rare neoplasms and for attempting to correct their frequent previous misclassification as sebaceous carcinomas through the years in several reference texts, including my own. [12] [13] [14] 16 Who knows how that misconception began? Probably one bad article way before even I started veterinary school; once something gets into print it may be cited generation after generation without ever being questioned.
The authors state that this is ''a new type of epithelial tumor in the dog that has not been reported in other species, including man.'' This does not appear to be the case. It has many features in common with some human malignant nodular hidradenomas (nodular hidradenocarcinoma, clear cell hidradenocarcinoma, porocarcinoma) that have a predominance of large clear cells; these have been recognized for half a century. [2] [3] [4] 6, 7, 9, 11, 15 As Dr. Summers has pointed out, according to the letter to the editor, four cases of clear cell hidradenocarcinoma in dogs were reported 25 years ago. 5 It is not difficult to determine sudoriferous origin (or at least sudoriferous differentiation) using readily available single keratin immunostains that are quite specific for sweat glands in canine skin. It is unfortunate that the authors chose to apply pancytokeratin as the only epithelial marker in their immunohistochemistry (IHC) protocol. In a small pilot study, 6/6 neoplasms of the type described in the article showed strong, diffuse, or multifocal positivity with CAM5.2 (E. J. Walder and T. L. Gross, unpublished). CAM5.2 (CK8) marks only sweat glands and follicular, inner root sheath in formalin-fixed, paraffin-embedded canine skin, and inner root sheath can easily be excluded on the basis of absence of trichohyalin granules. This information was shared with the authors before the publication of their article.
Regarding the authors' choice of nomenclature, I strongly believe that follicular stem cell carcinoma is inappropriate and misleading. Even without the knowledge that these are purely or predominantly apocrine neoplasms, there is no precedent to suggest that follicular stem cells can attain very large size and balloon-cell morphology. Quite the contrary, the current concept of the stem cell is a small cell; neoplasms of follicular stem cells would reasonably be expected to resemble trichoblastomas and basal cell carcinomas. Certainly, divergent differentiation in a stem cell pool within an adnexal neoplasm would allow for various combinations of follicular, apocrine, and sebaceous elements; this is well documented in the human literature, with the seboapocrine combination being most common. 1,10 However, Drs. Mikaelian and Wong provide little evidence of divergent differentiation. They often refer to ''trichoepitheliomatous'' features, but the requisite infundibular and matrical components of a panfollicular neoplasm, i.e., trichoepithelioma, are lacking. Glycogenic vacuolation of epithelial cells is assumed by the authors to be consonant with outer root sheath differentia-Letter to the Editor tion, as in tricholemmoma, but marked glycogen accumulation can be found in other tumor types, e.g., clear cell variants of several human sweat gland tumor types. On the basis of historic precedent, a close human analog, supportive IHC findings, and common sense, I urge that this neoplasm be referred to as clear cell or balloon-cell sweat gland carcinoma, at least until such time as sufficient evidence to the contrary is found.
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